Loading…
Lobbying Income
$60K
Filings
4
Unique Clients
1
Active Period
2022
Registrant-reported income from clients on LDA filings
Largest clients by registrant-reported income
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Consolidated Appropriations Act, 2023
2022 · fourth_quarter · Client: JUDGE ROTENBERG EDUCATIONAL CENTER, INC.
Opposition to provision in FDA User Fee Reauthorization that bans certain medical devices. H.R. 7667 / S. 4348, Food and Drug Amendments of 2022 and provision in Consolidated Appropriations Act, 2023, H.R.2617.
Client expense: — · Firm income: $30,000
Matched citations: H.R.2617
Food and Drug Amendments of 2022
2022 · fourth_quarter · Client: JUDGE ROTENBERG EDUCATIONAL CENTER, INC.
Opposition to provision in FDA User Fee Reauthorization that bans certain medical devices. H.R. 7667 / S. 4348, Food and Drug Amendments of 2022 and provision in Consolidated Appropriations Act, 2023, H.R.2617.
Client expense: — · Firm income: $30,000
Matched citations: H.R. 7667
FDASLA Act of 2022
2022 · fourth_quarter · Client: JUDGE ROTENBERG EDUCATIONAL CENTER, INC.
Opposition to provision in FDA User Fee Reauthorization that bans certain medical devices. H.R. 7667 / S. 4348, Food and Drug Amendments of 2022 and provision in Consolidated Appropriations Act, 2023, H.R.2617.
Client expense: — · Firm income: $30,000
Matched citations: S. 4348
Consolidated Appropriations Act, 2023
2022 · fourth_quarter · Client: JUDGE ROTENBERG EDUCATIONAL CENTER, INC.
Opposition to provision in FDA User Fee Reauthorization that bans certain medical devices. H.R. 7667 / S. 4348, Food and Drug Amendments of 2022 and provision in Consolidated Appropriations Act, 2023, H.R.2617.
Client expense: — · Firm income: $30,000
Matched citations: H.R.2617
Food and Drug Amendments of 2022
2022 · fourth_quarter · Client: JUDGE ROTENBERG EDUCATIONAL CENTER, INC.
Opposition to provision in FDA User Fee Reauthorization that bans certain medical devices. H.R. 7667 / S. 4348, Food and Drug Amendments of 2022 and provision in Consolidated Appropriations Act, 2023, H.R.2617.
Client expense: — · Firm income: $30,000
Matched citations: H.R. 7667
FDASLA Act of 2022
2022 · fourth_quarter · Client: JUDGE ROTENBERG EDUCATIONAL CENTER, INC.
Opposition to provision in FDA User Fee Reauthorization that bans certain medical devices. H.R. 7667 / S. 4348, Food and Drug Amendments of 2022 and provision in Consolidated Appropriations Act, 2023, H.R.2617.
Client expense: — · Firm income: $30,000
Matched citations: S. 4348
Food and Drug Amendments of 2022
2022 · third_quarter · Client: JUDGE ROTENBERG EDUCATIONAL CENTER, INC.
Opposition to provision in FDA User Fee Reauthorization that bans certain medical devices. H.R. 7667 / S. 4348, Food and Drug Amendments of 2022.
Client expense: — · Firm income: —
Matched citations: H.R. 7667
FDASLA Act of 2022
2022 · third_quarter · Client: JUDGE ROTENBERG EDUCATIONAL CENTER, INC.
Opposition to provision in FDA User Fee Reauthorization that bans certain medical devices. H.R. 7667 / S. 4348, Food and Drug Amendments of 2022.
Client expense: — · Firm income: —
Matched citations: S. 4348
Source: Senate LDA